by healthadvances Posted on March 29, 2023March 29, 2023 CNS Year in Review: Introduction and Large CNS Diseases Read More
by healthadvances Posted on March 28, 2023 Alumni Spotlight: Brittany Carroll, Vice President and Therapy Area Lead at Blueprint Medicines Read More
by healthadvances Posted on March 17, 2023 AAOS 2023: Implementing and Scaling New Technologies in a “Post-COVID World” Read More
by healthadvances Posted on March 9, 2023 Task Shifting in Reimagined Care Models and the Role of Technology Read More
by healthadvances Posted on March 8, 2023 AI in Healthcare: Implications at the Molecular, System, and Patient Level Read More
by healthadvances Posted on March 7, 2023 Is the Healthcare Industry Meeting the Rising Expectations of Consumers? Read More
by healthadvances Posted on February 22, 2023 The Humira Biosimilars Have Arrived! Will They Make a Difference? Read More
by healthadvances Posted on January 13, 2023 Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook Read More
by healthadvances Posted on January 4, 2023 Maturation of Modalities and Targeting Strategies in Oncology: A Review of Recent and Upcoming Approvals Read More
by healthadvances Posted on December 21, 2022 Allogeneic Cell Therapy: ASH 2022 Takeaways and Future Outlook Read More
by healthadvances Posted on November 15, 2022 Let’s Talk About Vaginismus and Digital Health Read More
by healthadvances Posted on October 31, 2022November 1, 2022 Relyvrio Approval: Lessons Learned Read More
by healthadvances Posted on September 21, 2022September 22, 2022 Digitalization in Pain Management: A Painless Effort? Read More
by healthadvances Posted on July 27, 2022July 27, 2022 What Do the Next 10 Years Hold for CRISPR? Read More
by healthadvances Posted on July 6, 2022July 21, 2022 Xenotransplantation: Market Disrupter or Expander? Read More
by healthadvances Posted on June 24, 2022June 24, 2022 From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology Read More
by healthadvances Posted on June 16, 2022June 16, 2022 ASCO 2022: Striving to Ensure No Patient is Left Behind Read More
by healthadvances Posted on May 2, 2022 Opportunities and Challenges for Drug Makers in MDD Read More
by healthadvances Posted on February 25, 2022 Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases Read More